Navigation Links
Innovation in science
Date:4/15/2010

Results of a study presented today at the at the International Liver CongressTM 2010 reveals the effects of a new drug for the treatment of primary biliary cirrhosis, and shows further evaluation is necessary.

INT-747 is a novel derivative of a human bile acid CDCA (that binds to the farnesoid-X receptor). In patients with PBC, addition of INT-747 to UDCA resulted in a significant amelioration of liver enzymes compared to placebo.

PBC is a chronic disease that damages bile ducts. Bile can no longer flow and builds up in the liver instead, damaging the liver cells and causing inflammation and scarring. This eventually leads to cirrhosis.


'/>"/>

Contact: Isabelle Scali
media.easl2010@cohnwolfe.com
44-771-743-5103
European Association for the Study of the Liver
Source:Eurekalert

Page: 1

Related biology news :

1. IEEE-USA innovation forum will help prepare US tech leaders to prosper in a global marketplace
2. First IEEE-USA Innovation Forum coming to Washington area in November
3. OHSU turns innovations into commercial opportunities at record pace
4. Synaptics SecurePad(TM) Selected as CES Innovations 2008 Design and Engineering Award Honoree
5. United Water, in partnership with Stevens, wins Management Innovation Award
6. How will government spur technological innovation in the 21st century?
7. Sonic Innovations Celebrates 10-Year Anniversary
8. Brown opens institute for molecular and nanoscale innovation
9. Atmel Receives Frost & Sullivans Technology Innovation Award for FingerChip(R) Biometric Sensor
10. Watson-inspired innovation in research at Cold Spring Harbor Laboratory
11. New chemical radar among national security innovations in ACS podcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/9/2016)... June 9, 2016  Perkotek an innovation leader in attendance control systems is proud ... work hours, for employers to make sure the right employees are actually signing in, ... ... ... ...
(Date:6/2/2016)...   The Weather Company , an IBM Business (NYSE: ... capability in which consumers will be able to interact with ... via voice or text and receive relevant information about the ... Marketers have long sought an advertising solution that can create ... relevant and valuable; and can scale across millions of interactions ...
(Date:5/16/2016)... YORK , May 16, 2016   EyeLock ... solutions, today announced the opening of an IoT Center ... to strengthen and expand the development of embedded iris ... an unprecedented level of convenience and security with unmatched ... authenticate one,s identity aside from DNA. EyeLock,s platform uses ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the ... at the Arkansas State Crime Laboratory, has joined STACS DNA as a Field Application ... team,” said Jocelyn Tremblay, President and COO of STACS DNA. “In further expanding our ...
(Date:6/23/2016)... , June 23, 2016  Blueprint Bio, a ... discoveries to the medical community, has closed its Series ... Matthew Nunez . "We have received a ... the capital we need to meet our current goals," ... provide us the runway to complete validation on the ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... the Pennsylvania Convention Center and will showcase its product’s latest features from June ... be presenting a scientific poster on Disrupting Clinical Trials in The Cloud during ...
(Date:6/23/2016)... -- Amgen (NASDAQ: AMGN ) today announced a ... sciences incubator to accelerate the development of new therapies ... QB3@953 was created to help high-potential life science and ... stage organizations - access to laboratory infrastructure. ... "Amgen Golden Ticket" awards, providing each winner with one ...
Breaking Biology Technology: